APO Research

APO RESEARCH · REPORT

Next Generation Sequencing (NGS) Service

Selected research

Market Outlook & Growth Opportunities

Global Next Generation Sequencing (NGS) Service Market Outlook and Growth Opportunities 2026

Market perspective

The global Next Generation Sequencing (NGS) Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Next Generation Sequencing (NGS) Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Next Generation Sequencing (NGS) Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Next Generation Sequencing (NGS) Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Next Generation Sequencing (NGS) Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Next Generation Sequencing (NGS) Service market include CLC Bio, GATC biotech AG, Macrogen, BGI (Beijing Genomics Institute), Illumina, Life Technology Corporation, EMC Corporation, Dnastar and 454 Life Sciences Corporation (Roche), among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Next Generation Sequencing (NGS) Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Next Generation Sequencing (NGS) Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Next Generation Sequencing (NGS) Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Next Generation Sequencing (NGS) Service market.

Next Generation Sequencing (NGS) Service Segment by Company

CLC Bio

GATC biotech AG

Macrogen

BGI (Beijing Genomics Institute)

Illumina

Life Technology Corporation

EMC Corporation

Dnastar

454 Life Sciences Corporation (Roche)

Agilent Technologies

Biomatters, Ltd

Next Generation Sequencing (NGS) Service Segment by Type

Targeted Sequencing & Resequencing

Whole Genome Sequencing

Whole Exome Sequencing

Next Generation Sequencing (NGS) Service Segment by Application

Whole-genome Sequencing

Exome Sequencing

Targeted Resequencing

De Novo Sequencing

RNA Sequencing

ChIP Sequencing

Methyl Sequencing

Others

Next Generation Sequencing (NGS) Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Next Generation Sequencing (NGS) Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Next Generation Sequencing (NGS) Service key companies, revenue, market share, and recent developments.

3. To split the Next Generation Sequencing (NGS) Service breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Next Generation Sequencing (NGS) Service market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Next Generation Sequencing (NGS) Service significant trends, drivers, influence factors in global and regions.

6. To analyze Next Generation Sequencing (NGS) Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Next Generation Sequencing (NGS) Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Next Generation Sequencing (NGS) Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Next Generation Sequencing (NGS) Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Next Generation Sequencing (NGS) Service industry.

Chapter 3: Detailed analysis of Next Generation Sequencing (NGS) Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Next Generation Sequencing (NGS) Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Next Generation Sequencing (NGS) Service in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Next Generation Sequencing (NGS) Service Industry Trends Table 2. Next Generation Sequencing (NGS) Service Industry Drivers Table 3. Next Generation Sequencing (NGS) Service Industry Opportunities and Challenges Table 4. Next Generation Sequencing (NGS) Service Industry Restraints Table 5. Global Next Generation Sequencing (NGS) Service Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Next Generation Sequencing (NGS) Service Revenue Share by Company (2021-2026) Table 7. Global Next Generation Sequencing (NGS) Service Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Next Generation Sequencing (NGS) Service Key Company Manufacturing Base & Headquarters Table 9. Global Next Generation Sequencing (NGS) Service Company, Product Type & Application Table 10. Global Next Generation Sequencing (NGS) Service Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Next Generation Sequencing (NGS) Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Targeted Sequencing & Resequencing Table 15. Significant Companies of Whole Genome Sequencing Table 16. Significant Companies of Whole Exome Sequencing Table 17. Global Next Generation Sequencing (NGS) Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Next Generation Sequencing (NGS) Service Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Next Generation Sequencing (NGS) Service Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Next Generation Sequencing (NGS) Service Sales Value Share by Type (2021-2026) Table 21. Global Next Generation Sequencing (NGS) Service Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Whole-genome Sequencing Table 23. Significant Companies of Exome Sequencing Table 24. Significant Companies of Targeted Resequencing Table 25. Significant Companies of De Novo Sequencing Table 26. Significant Companies of RNA Sequencing Table 27. Significant Companies of ChIP Sequencing Table 28. Significant Companies of Methyl Sequencing Table 29. Significant Companies of Others Table 30. Global Next Generation Sequencing (NGS) Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Next Generation Sequencing (NGS) Service Sales Value by Application (2021-2026) & (US$ Million) Table 32. Global Next Generation Sequencing (NGS) Service Sales Value by Application (2027-2032) & (US$ Million) Table 33. Global Next Generation Sequencing (NGS) Service Sales Value Share by Application (2021-2026) Table 34. Global Next Generation Sequencing (NGS) Service Sales Value Share by Application (2027-2032) Table 35. Global Next Generation Sequencing (NGS) Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Next Generation Sequencing (NGS) Service Sales Value by Region (2021-2026) & (US$ Million) Table 37. Global Next Generation Sequencing (NGS) Service Sales Value Share by Region (2021-2026) Table 38. Global Next Generation Sequencing (NGS) Service Sales Value by Region (2027-2032) & (US$ Million) Table 39. Global Next Generation Sequencing (NGS) Service Sales Value Share by Region (2027-2032) Table 40. Global Next Generation Sequencing (NGS) Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Next Generation Sequencing (NGS) Service Sales Value by Country (2021-2026) & (US$ Million) Table 42. Global Next Generation Sequencing (NGS) Service Sales Value Market Share by Country (2021-2026) Table 43. Global Next Generation Sequencing (NGS) Service Sales Value by Country (2027-2032) & (US$ Million) Table 44. Global Next Generation Sequencing (NGS) Service Sales Value Market Share by Country (2027-2032) Table 45. CLC Bio Company Information Table 46. CLC Bio Business Overview Table 47. CLC Bio Next Generation Sequencing (NGS) Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. CLC Bio Next Generation Sequencing (NGS) Service Product Portfolio Table 49. CLC Bio Recent Development Table 50. GATC biotech AG Company Information Table 51. GATC biotech AG Business Overview Table 52. GATC biotech AG Next Generation Sequencing (NGS) Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. GATC biotech AG Next Generation Sequencing (NGS) Service Product Portfolio Table 54. GATC biotech AG Recent Development Table 55. Macrogen Company Information Table 56. Macrogen Business Overview Table 57. Macrogen Next Generation Sequencing (NGS) Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Macrogen Next Generation Sequencing (NGS) Service Product Portfolio Table 59. Macrogen Recent Development Table 60. BGI (Beijing Genomics Institute) Company Information Table 61. BGI (Beijing Genomics Institute) Business Overview Table 62. BGI (Beijing Genomics Institute) Next Generation Sequencing (NGS) Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. BGI (Beijing Genomics Institute) Next Generation Sequencing (NGS) Service Product Portfolio Table 64. BGI (Beijing Genomics Institute) Recent Development Table 65. Illumina Company Information Table 66. Illumina Business Overview Table 67. Illumina Next Generation Sequencing (NGS) Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Illumina Next Generation Sequencing (NGS) Service Product Portfolio Table 69. Illumina Recent Development Table 70. Life Technology Corporation Company Information Table 71. Life Technology Corporation Business Overview Table 72. Life Technology Corporation Next Generation Sequencing (NGS) Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Life Technology Corporation Next Generation Sequencing (NGS) Service Product Portfolio Table 74. Life Technology Corporation Recent Development Table 75. EMC Corporation Company Information Table 76. EMC Corporation Business Overview Table 77. EMC Corporation Next Generation Sequencing (NGS) Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. EMC Corporation Next Generation Sequencing (NGS) Service Product Portfolio Table 79. EMC Corporation Recent Development Table 80. Dnastar Company Information Table 81. Dnastar Business Overview Table 82. Dnastar Next Generation Sequencing (NGS) Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Dnastar Next Generation Sequencing (NGS) Service Product Portfolio Table 84. Dnastar Recent Development Table 85. 454 Life Sciences Corporation (Roche) Company Information Table 86. 454 Life Sciences Corporation (Roche) Business Overview Table 87. 454 Life Sciences Corporation (Roche) Next Generation Sequencing (NGS) Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. 454 Life Sciences Corporation (Roche) Next Generation Sequencing (NGS) Service Product Portfolio Table 89. 454 Life Sciences Corporation (Roche) Recent Development Table 90. Agilent Technologies Company Information Table 91. Agilent Technologies Business Overview Table 92. Agilent Technologies Next Generation Sequencing (NGS) Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Agilent Technologies Next Generation Sequencing (NGS) Service Product Portfolio Table 94. Agilent Technologies Recent Development Table 95. Biomatters, Ltd Company Information Table 96. Biomatters, Ltd Business Overview Table 97. Biomatters, Ltd Next Generation Sequencing (NGS) Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Biomatters, Ltd Next Generation Sequencing (NGS) Service Product Portfolio Table 99. Biomatters, Ltd Recent Development Table 100. Research Programs/Design for This Report Table 101. Authors List of This Report Table 102. Secondary Sources Table 103. Primary Sources List of Figures Figure 1. Next Generation Sequencing (NGS) Service Product Image Figure 2. Global Next Generation Sequencing (NGS) Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Next Generation Sequencing (NGS) Service Market Size (2021-2032) & (US$ Million) Figure 4. Global Next Generation Sequencing (NGS) Service Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Targeted Sequencing & Resequencing Image Figure 8. Whole Genome Sequencing Image Figure 9. Whole Exome Sequencing Image Figure 10. Global Next Generation Sequencing (NGS) Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Next Generation Sequencing (NGS) Service Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Next Generation Sequencing (NGS) Service Sales Value Share by Type (2021-2032) Figure 13. Whole-genome Sequencing Image Figure 14. Exome Sequencing Image Figure 15. Targeted Resequencing Image Figure 16. De Novo Sequencing Image Figure 17. RNA Sequencing Image Figure 18. ChIP Sequencing Image Figure 19. Methyl Sequencing Image Figure 20. Others Image Figure 21. Global Next Generation Sequencing (NGS) Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Next Generation Sequencing (NGS) Service Sales Value Share 2021 VS 2025 VS 2032 Figure 23. Global Next Generation Sequencing (NGS) Service Sales Value Share by Application (2021-2032) Figure 24. Global Next Generation Sequencing (NGS) Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 25. Global Next Generation Sequencing (NGS) Service Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 26. North America Next Generation Sequencing (NGS) Service Sales Value (2021-2032) & (US$ Million) Figure 27. North America Next Generation Sequencing (NGS) Service Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Europe Next Generation Sequencing (NGS) Service Sales Value (2021-2032) & (US$ Million) Figure 29. Europe Next Generation Sequencing (NGS) Service Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Asia-Pacific Next Generation Sequencing (NGS) Service Sales Value (2021-2032) & (US$ Million) Figure 31. Asia-Pacific Next Generation Sequencing (NGS) Service Sales Value Share by Country (%), 2025 VS 2032 Figure 32. South America Next Generation Sequencing (NGS) Service Sales Value (2021-2032) & (US$ Million) Figure 33. South America Next Generation Sequencing (NGS) Service Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Middle East & Africa Next Generation Sequencing (NGS) Service Sales Value (2021-2032) & (US$ Million) Figure 35. Middle East & Africa Next Generation Sequencing (NGS) Service Sales Value Share by Country (%), 2025 VS 2032 Figure 36. USA Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. USA Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. USA Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Canada Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Canada Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Canada Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Mexico Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Mexico Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Mexico Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Germany Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Germany Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Germany Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. France Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. France Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. France Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. U.K. Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. U.K. Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. U.K. Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Italy Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Italy Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Italy Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Spain Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Spain Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Spain Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Russia Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Russia Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Russia Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Netherlands Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Netherlands Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Netherlands Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Nordic Countries Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Nordic Countries Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Nordic Countries Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. China Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. China Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. China Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Japan Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Japan Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Japan Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. South Korea Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. South Korea Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. South Korea Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. India Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. India Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. India Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Australia Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Australia Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Australia Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Southeast Asia Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Southeast Asia Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Southeast Asia Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Brazil Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Brazil Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Brazil Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Argentina Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Argentina Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Argentina Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Chile Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Chile Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Chile Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Colombia Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Colombia Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Colombia Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Peru Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Peru Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Peru Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Saudi Arabia Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Saudi Arabia Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Saudi Arabia Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Israel Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Israel Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Israel Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. UAE Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. UAE Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. UAE Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Turkey Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Turkey Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Turkey Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Iran Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Iran Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Iran Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Egypt Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Egypt Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Egypt Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Years Considered Figure 121. Research Process Figure 122. Key Executives Interviewed

Scope & coverage.

Types
  • Targeted Sequencing & Resequencing
  • Whole Genome Sequencing
  • Whole Exome Sequencing
Applications
  • Whole-genome Sequencing
  • Exome Sequencing
  • Targeted Resequencing
  • De Novo Sequencing
  • RNA Sequencing
  • ChIP Sequencing
  • Methyl Sequencing
  • Others
Companies covered
  • CLC Bio
  • GATC biotech AG
  • Macrogen
  • BGI (Beijing Genomics Institute)
  • Illumina
  • Life Technology Corporation
  • EMC Corporation
  • Dnastar
  • 454 Life Sciences Corporation (Roche)
  • Agilent Technologies
  • Biomatters, Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Next Generation Sequencing (NGS) Service Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Next Generation Sequencing (NGS) Service Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Next Generation Sequencing (NGS) Service Market Dynamics
  1. 2.1 Next Generation Sequencing (NGS) Service Industry Trends
  2. 2.2 Next Generation Sequencing (NGS) Service Industry Drivers
  3. 2.3 Next Generation Sequencing (NGS) Service Industry Opportunities and Challenges
  4. 2.4 Next Generation Sequencing (NGS) Service Industry Restraints
3 Next Generation Sequencing (NGS) Service Market by Company
  1. 3.1 Global Next Generation Sequencing (NGS) Service Company Revenue Ranking in 2025
  2. 3.2 Global Next Generation Sequencing (NGS) Service Revenue by Company (2021-2026)
  3. 3.3 Global Next Generation Sequencing (NGS) Service Company Ranking (2024-2026)
  4. 3.4 Global Next Generation Sequencing (NGS) Service Company Manufacturing Base and Headquarters
  5. 3.5 Global Next Generation Sequencing (NGS) Service Company Product Type and Application
  6. 3.6 Global Next Generation Sequencing (NGS) Service Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Next Generation Sequencing (NGS) Service Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Next Generation Sequencing (NGS) Service Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Next Generation Sequencing (NGS) Service Market by Type
  1. 4.1 Next Generation Sequencing (NGS) Service Type Introduction
  2. 4.1.1 Targeted Sequencing & Resequencing
  3. 4.1.2 Whole Genome Sequencing
  4. 4.1.3 Whole Exome Sequencing
  5. 4.2 Global Next Generation Sequencing (NGS) Service Sales Value by Type
  6. 4.2.1 Global Next Generation Sequencing (NGS) Service Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Next Generation Sequencing (NGS) Service Sales Value by Type (2021-2032)
  8. 4.2.3 Global Next Generation Sequencing (NGS) Service Sales Value Share by Type (2021-2032)
5 Next Generation Sequencing (NGS) Service Market by Application
  1. 5.1 Next Generation Sequencing (NGS) Service Application Introduction
  2. 5.1.1 Whole-genome Sequencing
  3. 5.1.2 Exome Sequencing
  4. 5.1.3 Targeted Resequencing
  5. 5.1.4 De Novo Sequencing
  6. 5.1.5 RNA Sequencing
  7. 5.1.6 ChIP Sequencing
  8. 5.1.7 Methyl Sequencing
  9. 5.1.8 Others
  10. 5.2 Global Next Generation Sequencing (NGS) Service Sales Value by Application
  11. 5.2.1 Global Next Generation Sequencing (NGS) Service Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.2.2 Global Next Generation Sequencing (NGS) Service Sales Value by Application (2021-2032)
  13. 5.2.3 Global Next Generation Sequencing (NGS) Service Sales Value Share by Application (2021-2032)
6 Next Generation Sequencing (NGS) Service Regional Value Analysis
  1. 6.1 Global Next Generation Sequencing (NGS) Service Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Next Generation Sequencing (NGS) Service Sales Value by Region (2021-2032)
  3. 6.2.1 Global Next Generation Sequencing (NGS) Service Sales Value by Region: 2021-2026
  4. 6.2.2 Global Next Generation Sequencing (NGS) Service Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Next Generation Sequencing (NGS) Service Sales Value (2021-2032)
  7. 6.3.2 North America Next Generation Sequencing (NGS) Service Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Next Generation Sequencing (NGS) Service Sales Value (2021-2032)
  10. 6.4.2 Europe Next Generation Sequencing (NGS) Service Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Next Generation Sequencing (NGS) Service Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Next Generation Sequencing (NGS) Service Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Next Generation Sequencing (NGS) Service Sales Value (2021-2032)
  16. 6.6.2 South America Next Generation Sequencing (NGS) Service Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Next Generation Sequencing (NGS) Service Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Next Generation Sequencing (NGS) Service Sales Value Share by Country, 2025 VS 2032
7 Next Generation Sequencing (NGS) Service Country-level Value Analysis
  1. 7.1 Global Next Generation Sequencing (NGS) Service Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Next Generation Sequencing (NGS) Service Sales Value by Country (2021-2032)
  3. 7.2.1 Global Next Generation Sequencing (NGS) Service Sales Value by Country (2021-2026)
  4. 7.2.2 Global Next Generation Sequencing (NGS) Service Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Next Generation Sequencing (NGS) Service Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Next Generation Sequencing (NGS) Service Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Next Generation Sequencing (NGS) Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 CLC Bio
  2. 8.1.1 CLC Bio Company Information
  3. 8.1.2 CLC Bio Business Overview
  4. 8.1.3 CLC Bio Next Generation Sequencing (NGS) Service Revenue and Gross Margin (2021-2026)
  5. 8.1.4 CLC Bio Next Generation Sequencing (NGS) Service Product Portfolio
  6. 8.1.5 CLC Bio Recent Developments
  7. 8.2 GATC biotech AG
  8. 8.2.1 GATC biotech AG Company Information
  9. 8.2.2 GATC biotech AG Business Overview
  10. 8.2.3 GATC biotech AG Next Generation Sequencing (NGS) Service Revenue and Gross Margin (2021-2026)
  11. 8.2.4 GATC biotech AG Next Generation Sequencing (NGS) Service Product Portfolio
  12. 8.2.5 GATC biotech AG Recent Developments
  13. 8.3 Macrogen
  14. 8.3.1 Macrogen Company Information
  15. 8.3.2 Macrogen Business Overview
  16. 8.3.3 Macrogen Next Generation Sequencing (NGS) Service Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Macrogen Next Generation Sequencing (NGS) Service Product Portfolio
  18. 8.3.5 Macrogen Recent Developments
  19. 8.4 BGI (Beijing Genomics Institute)
  20. 8.4.1 BGI (Beijing Genomics Institute) Company Information
  21. 8.4.2 BGI (Beijing Genomics Institute) Business Overview
  22. 8.4.3 BGI (Beijing Genomics Institute) Next Generation Sequencing (NGS) Service Revenue and Gross Margin (2021-2026)
  23. 8.4.4 BGI (Beijing Genomics Institute) Next Generation Sequencing (NGS) Service Product Portfolio
  24. 8.4.5 BGI (Beijing Genomics Institute) Recent Developments
  25. 8.5 Illumina
  26. 8.5.1 Illumina Company Information
  27. 8.5.2 Illumina Business Overview
  28. 8.5.3 Illumina Next Generation Sequencing (NGS) Service Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Illumina Next Generation Sequencing (NGS) Service Product Portfolio
  30. 8.5.5 Illumina Recent Developments
  31. 8.6 Life Technology Corporation
  32. 8.6.1 Life Technology Corporation Company Information
  33. 8.6.2 Life Technology Corporation Business Overview
  34. 8.6.3 Life Technology Corporation Next Generation Sequencing (NGS) Service Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Life Technology Corporation Next Generation Sequencing (NGS) Service Product Portfolio
  36. 8.6.5 Life Technology Corporation Recent Developments
  37. 8.7 EMC Corporation
  38. 8.7.1 EMC Corporation Company Information
  39. 8.7.2 EMC Corporation Business Overview
  40. 8.7.3 EMC Corporation Next Generation Sequencing (NGS) Service Revenue and Gross Margin (2021-2026)
  41. 8.7.4 EMC Corporation Next Generation Sequencing (NGS) Service Product Portfolio
  42. 8.7.5 EMC Corporation Recent Developments
  43. 8.8 Dnastar
  44. 8.8.1 Dnastar Company Information
  45. 8.8.2 Dnastar Business Overview
  46. 8.8.3 Dnastar Next Generation Sequencing (NGS) Service Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Dnastar Next Generation Sequencing (NGS) Service Product Portfolio
  48. 8.8.5 Dnastar Recent Developments
  49. 8.9 454 Life Sciences Corporation (Roche)
  50. 8.9.1 454 Life Sciences Corporation (Roche) Company Information
  51. 8.9.2 454 Life Sciences Corporation (Roche) Business Overview
  52. 8.9.3 454 Life Sciences Corporation (Roche) Next Generation Sequencing (NGS) Service Revenue and Gross Margin (2021-2026)
  53. 8.9.4 454 Life Sciences Corporation (Roche) Next Generation Sequencing (NGS) Service Product Portfolio
  54. 8.9.5 454 Life Sciences Corporation (Roche) Recent Developments
  55. 8.10 Agilent Technologies
  56. 8.10.1 Agilent Technologies Company Information
  57. 8.10.2 Agilent Technologies Business Overview
  58. 8.10.3 Agilent Technologies Next Generation Sequencing (NGS) Service Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Agilent Technologies Next Generation Sequencing (NGS) Service Product Portfolio
  60. 8.10.5 Agilent Technologies Recent Developments
  61. 8.11 Biomatters, Ltd
  62. 8.11.1 Biomatters, Ltd Company Information
  63. 8.11.2 Biomatters, Ltd Business Overview
  64. 8.11.3 Biomatters, Ltd Next Generation Sequencing (NGS) Service Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Biomatters, Ltd Next Generation Sequencing (NGS) Service Product Portfolio
  66. 8.11.5 Biomatters, Ltd Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research